|
Market Closed -
Nasdaq
08:00:00 07/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 29.87 USD | +5.66% |
|
-0.76% | +9.98% |
| 06/11 | Celldex Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 23/09 | Top Midday Decliners | MT |
| Market Cap | 2.35B 2.1B 1.92B 1.76B 3.31B 220B 3.41B 23.18B 9.24B 118B 8.8B 8.62B 371B | P/E 2026 * |
-7.12x | P/E 2027 * | -6.98x |
|---|---|---|---|---|---|
| Enterprise Value | 1.76B 1.58B 1.44B 1.31B 2.48B 165B 2.55B 17.35B 6.92B 88.1B 6.59B 6.45B 278B | EV / Sales 2026 * |
1,105x | EV / Sales 2027 * | 193x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CLDX | Delayed | |
CBOE
| CLDX | Real-time | |
|
Tradegate
| TCE2 | Real-time | |
|
Boerse Muenchen
| TCE2 | Real-time | |
|
Deutsche Boerse AG
| TCE2 | Delayed | |
|
Börse Stuttgart
| TCE2 | Delayed | |
|
Berne S.E.
| TCE1 | End-of-day quote |
Last Transcript: Celldex Therapeutics, Inc.
| 1 day | +5.66% | ||
| 1 week | -0.76% | ||
| Current month | -0.76% | ||
| 1 month | -3.66% | ||
| 3 months | -28.13% | ||
| 6 months | -13.14% | ||
| Current year | +9.98% |
| 1 week | 27.82 |  | 30.92 |
| 1 month | 27.46 | | 30.92 |
| Current year | 22.33 | | 45.14 |
| 1 year | 22.1 | | 45.14 |
| 3 years | 14.4 | | 53.18 |
| 5 years | 14.4 | | 53.18 |
| 10 years | 1.5 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tibor Keler
CTO | Chief Tech/Sci/R&D Officer | 67 | 30/07/2014 |
Anthony Marucci
CEO | Chief Executive Officer | 64 | 01/09/2008 |
Sam Martin
DFI | Director of Finance/CFO | 55 | 01/04/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 64 | 01/12/2008 |
Harry Penner
CHM | Chairman | 80 | 05/06/2025 |
Herbert Conrad
BRD | Director/Board Member | 93 | 01/03/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/6/26 | Free | Executive/Senior Manager | 20,000 | 0.0255% | ||
| 25/6/26 | Free | Director | 26,000 | 0.0331% | ||
| 25/6/26 | Free | Chief Technology Officer | 57,000 | 0.0726% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.66% | -0.76% | +28.42% | +1.77% | 2.22B | |
| -4.83% | +3.51% | +53.62% | +61.75% | 69.4B | |
| -1.34% | +2.98% | +24.79% | +100.18% | 57.62B | |
| +0.02% | +1.07% | +10.63% | +76.66% | 57.24B | |
| +5.09% | +9.89% | +22.45% | +107.48% | 44.03B | |
| +2.62% | +1.68% | +28.91% | +37.01% | 43.65B | |
| +8.24% | +0.51% | +213.26% | +792.66% | 38.08B | |
| -1.86% | +10.13% | +26.82% | +53.22% | 36.31B | |
| -2.97% | -9.84% | +88.86% | +76.17% | 32.61B | |
| -2.18% | +7.06% | +36.06% | -4.95% | 25.47B | |
| Average | +0.85% | +3.72% | +53.38% | +130.20% | 40.66B | |
| Weighted average by Cap. | +0.08% | +4.23% | +51.60% | +135.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85M 1.66M 1.52M 1.38M 2.61M 174M 2.69M 18.28M 7.29M 92.79M 6.94M 6.79M 293M | 8.76M 7.86M 7.18M 6.55M 12.35M 823M 12.74M 86.55M 34.51M 439M 32.88M 32.17M 1.39B |
| Net income | -319M -286M -262M -239M -450M -30B -464M -3.15B -1.26B -16.01B -1.2B -1.17B -50.54B | -361M -324M -296M -270M -509M -33.93B -525M -3.57B -1.42B -18.1B -1.35B -1.33B -57.15B |
| Net Debt | -589M -528M -483M -441M -831M -55.39B -857M -5.82B -2.32B -29.55B -2.21B -2.16B -93.29B | -547M -491M -449M -409M -771M -51.44B -796M -5.41B -2.16B -27.45B -2.05B -2.01B -86.64B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | USD 29.87 | +5.66% | 926,318 |
| 05/11/26 | USD 28.27 | -5.55% | 1,111,363 |
| 04/11/26 | USD 29.93 | +0.74% | 911,485 |
| 03/11/26 | USD 29.71 | +2.31% | 872,044 |
| 02/11/26 | USD 29.04 | -3.52% | 956,133 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLDX Stock
Select your edition
All financial news and data tailored to specific country editions
